Intravitreal injections: taking the plunge

29 October 2021
Autumn 2021

Increasing demand for intravitreal injections to treat conditions such as wet AMD provides an opportunity for optometrists to widen their portfolio of skills, writes Kim Thomas.

Part of the success of the COVID-19 vaccination programme was down to the many optometrists and other healthcare professionals who helped deliver the vaccine. Now the programme is nearing its end, could optometrists use their newly acquired skills to take on another role – that of intravitreal injector?

Sign in to continue

Forgotten password?
Register

Not already a member of the College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Reviewing the evidence for the role of supplements in eye health, particularly cataract and age-related macular degeneration (AMD).

Our Clinical Adviser comments on the story in the BBC about the woman who had gene therapy to try to halt the progression of age-related macular degeneration (AMD).